G16V (p.Gly16Val) variant of DRD3 (Dopamine receptor D3)

G16V (p.Gly16Val) in DRD3 (Dopamine receptor D3) is a missense change. Clinical records from EBI and UniProt describe it as uncertain significance. The available variant effect predictions contribute to a CATVariant prioritization score of 0.30 / 1. The record also includes population frequency data and structural context.

G16V (p.Gly16Val) variant details